Projects | euresist

PROJECTS

EuCARE: European Cohorts of Patients and Schools to Advance Response to Epidemics

Coordinated by Euresist Network, 22 primary universities, hospitals and ICT research centres are collaborating to provide robust, data driven evidence to deal with SARS-CoV-2 variants and COVID-19 epidemics.

How do SARS-COV-2 variants, coupled with other factors, influence the clinical course of COVID-19? Is there any vaccine or test escape related to variants? Do variants influence, and how, the spread in the school setting? Can we define a better testing and containment strategy in the school setting? What is the impact of containment measures, including schools closure, on pupils and teachers?

With the support of strong immuno-virological and artificial intelligence components, the study will take advantage of large hospital patients, vaccinated healthcare workers and schools’ cohorts in Europe, Kenya, Mexico and Brizil to find an answer to urgent issues related to science and society....

AVITHRAPID

The fight against global health threats from viral diseases takes a big step forward with AVITHRAPID "Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases". This ambitious project aims to create a pipeline of promising antiviral drugs built on existing small molecules with proven effectiveness against various viruses.

CARE

CARE (Common Action against HIV/TB/HCV across the Regions of Europe) aims at analysing and addressing the human immunodeficiency virus (HIV), tuberculosis (TB) and hepatitis C (HCV) epidemics across Europe and Russia, by establishing new networks and consolidating previous cooperative actions between the European Union and the Russian Federation.

Integrate

The INTEGRATE project aims at building and maintaining a large, curated collection of virological and clinical data to increase scientific knowledge on resistance to integrase strand transfer inhibitors (InSTI) and on the most appropriate use of this class of antiretroviral agents.

EuResist Mentor School

EuResist Network organises the EuResist Mentor School (EMS) an innovative educational project finalised to train young physicians and biologists in dealing with structured data (databases). The EMS 2018 has been successfully held in Cologne

EuResist in Africa

EuResist has been supporting partner of the EDCTP networking action: "Integrated training activities and IT infrastructures to improve capacities in eastern African area"...

EucoHIV

EucoHIV is an independent self-constituted study group aiming at increasing scientific knowledge on HIV coreceptor usage and its clinical significance, including...

Varuna

The VARUNA on-line self assessment platform has the objectives to:

quantify GCP compliance in HIV care across Europe,
identify RT tools routinely used in clinical practice across Europe,
analyse it by geography as well as to
use self-assessment as a strategy for promotion of GCP compliance

ARCA Mentor School

EuResist Network participates in the Arca Mentor School (AMS) an innovative educational project conceived, organised and realised by the ARCA scientific Board, Intramed Communications and I-PRO....

EDCTP ENEAA project

EuResist has been supporting partner of the EDCTP networking action:

"Integrated training activities and IT infrastructures to improve capacities in eastern African area: European Network in Eastern African Area – ENEAA project" (EDCTP JP.2009.10800.002).

KRG - DHIS

EuResist Network participates in the pilot project for the realization of a System of Health Monitoring and Surveillance activities in the Autonomous Region of Kurdistan...

CHAIN

The CHAIN project aims at combat new and existing anti-HIV drug resistance in clinical settings, with a special emphasis on Eastern Europe and Africa...

MDR

The MDR project (HIV multidrug resistance pathways in the EuResist Integrated DataBase) aims at estimating the prevalence and trend over time of MDR (multidrug resistance) in HIV patients, using descriptive statistics, retaining high value because of the large sample size and wide representativeness of the EIDB.